dipalmitoylphosphatidic acid has been researched along with Experimental Neoplasms in 1 studies
dipalmitoylphosphatidic acid: RN given refers to parent cpd without isomeric designation
dihexadecanoyl phosphatidic acid : A phosphatidic acid in which the phosphatidyl acyl groups are both palmitoyl (hexadecanoyl).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, T | 1 |
| Shimizu, K | 1 |
| Kondo, M | 1 |
| Kuromi, K | 1 |
| Watanabe, K | 1 |
| Ogino, K | 1 |
| Taki, T | 1 |
| Shuto, S | 1 |
| Matsuda, A | 1 |
| Oku, N | 1 |
1 other study available for dipalmitoylphosphatidic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cytarabine; Drug Delivery Systems; Liposomes; | 2002 |